What does CUSIP 803607AC4 represent in this 13F holders report?

CUSIP 803607AC4 is the security identifier for 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 used to aggregate holder disclosures.

How many institutions held 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 in Q3 2023?

No institutional holders were reported for 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 in Q3 2023; review adjacent reporting periods for trend context.

SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1

CUSIP: 803607AC4

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Debt / DEBT 1.250% 9/1
Total 13F principal: $0
Principal change: -$15,451,000
Total reported market value: $0
Number of holders: 0
Value change: -$16,747,188
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 803607AC4?
CUSIP 803607AC4 identifies 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2023

Recent filing periods for CUSIP 803607AC4:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1

Q3 2023 13F Holders as of 30 Sep 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 as of Q3 2023.